Pharmacoinformatics study of Piperolactam A from Piper betle root as new lead for non steroidal anti fertility drug development

Fertility control is a burning problem all over the world to regulate population overflow and maintain ecological balance. This study is an in-silico approach to explore a non-steroidal lead as contraceptive agent in order to avoid several contraindications generated by steroidal analogues. Piperolactam A, an aristolactam isolated from Piper betle Linn. showed binding affinity towards estrogen and progesterone receptor as -8.9 and -9.0Kcal/mol (inhibition constant Ki=0.294μM and 0.249μM) respectively which is even larger than that of reported antagonists such as Rohitukine and OrgC (binding affinity -8.7 and -8.4Kcal/mol; Ki 0.443μM and 0.685μM respectively). The binding site exploration displayed more hydrogen bonding of Piperolactam A (His 524, Leu 346, Thr 347) than Rohitukine and OrgC (Leu 718) with associated receptors which was further confirmed by molecular dynamics simulations. The drug-likeliness of the compound has been proved from its tally with Lipinsky's Rule of Five and lowered toxicity such as cardiac toxicity, liver toxicity, mutagenicity and ecological toxicity. Endocrine disruptome and later docking guided molecular simulations revealed that Piperolactam A has weaker binding affinity and/or lower probability of binding with nuclear receptors especially hERG and cytochrome P450. The high Caco-2 permeability suggested more bioavailability hence more therapeutic efficacy of the drug.

[1]  Luhua Lai,et al.  Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..

[2]  Chia-Ning Yang,et al.  Molecular modelling studies of sirtuin 2 inhibitors using three-dimensional structure-activity relationship analysis and molecular dynamics simulations. , 2015, Molecular bioSystems.

[3]  N. Hooper,et al.  The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill , 2008, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[4]  P. Artursson,et al.  Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers , 2007, Nature Protocols.

[5]  G. Jena,et al.  Genotoxicity testing, a regulatory requirement for drug discovery and development: Impact of ICH guidelines , 2002 .

[6]  M. Andersson,et al.  Progesterone receptor antagonists Org 31710 and RU 486 increase apoptosis in human periovulatory granulosa cells. , 2001, Fertility and sterility.

[7]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[8]  S. Nussey,et al.  Endocrinology: An Integrated Approach , 2001 .

[9]  T. Lynch,et al.  The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. , 2007, American family physician.

[10]  S. Dutta.  A REVIEW OF PLANTS USED AS CONTRACEPTIVES , 2015 .

[11]  M. Singh,et al.  Contraceptive and hormonal properties of the stem bark of Dysoxylum binectariferum in rat and docking analysis of rohitukine, the alkaloid isolated from active chloroform soluble fraction. , 2007, Contraception.

[12]  Samo Turk,et al.  Endocrine Disruptome - An Open Source Prediction Tool for Assessing Endocrine Disruption Potential through Nuclear Receptor Binding , 2014, J. Chem. Inf. Model..

[13]  J J Baldwin,et al.  Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.

[14]  Vivekanandan.K Bhavya.E Stalin.C.  Medicinal Plants with Antifertility Activity-An Overview , 2013 .

[15]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[16]  Haibo Yu,et al.  hERGCentral: a large database to store, retrieve, and analyze compound-human Ether-à-go-go related gene channel interactions to facilitate cardiotoxicity assessment in drug development. , 2011, Assay and drug development technologies.

[17]  Jie Shen,et al.  admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties , 2012, J. Chem. Inf. Model..

[18]  M. Shaarawy,et al.  Serotonin metabolism and depression in oral contraceptive users. , 1982, Contraception.

[19]  Kenneth M Merz,et al.  Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships. , 2003, Journal of medicinal chemistry.

[20]  Weida Tong,et al.  Homology modeling, molecular docking, and molecular dynamics simulations elucidated α-fetoprotein binding modes , 2013, BMC Bioinformatics.

[21]  Steven L. Dixon,et al.  Use of Robust Classification Techniques for the Prediction of Human Cytochrome P450 2D6 Inhibition. , 2003 .

[22]  M. Jagadeesan,et al.  Pharmacognostical and Phyto-physicochemical profile of the leaves of Piper betle L. var Pachaikodi (Piperaceae) — Valuable assessment of its quality , 2012 .

[23]  L. Nilsson,et al.  Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K , 2001 .

[24]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[25]  Dibyabhaba Pradhan,et al.  Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study , 2014, Journal of biomolecular structure & dynamics.

[26]  Saba Ferdous,et al.  Glycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson’s disease: a pharmacoinformatics study , 2014, Drug design, development and therapy.

[27]  S. Hamdan,et al.  Modeling and Docking Studies on Novel Mutants (K71L and T204V) of the ATPase Domain of Human Heat Shock 70 kDa Protein 1 , 2014, International journal of molecular sciences.

[28]  Yumi N Imai,et al.  Docking model of drug binding to the human ether-à-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach. , 2009, Journal of medicinal chemistry.

[29]  J. A. Kanis,et al.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women , 2013, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

[30]  M. Vračko,et al.  Computational study of binding affinity to nuclear receptors for some cosmetic ingredients. , 2015, Chemosphere.

[31]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.